doi:10.1007/s12250-019-00183-4

[1]
Yu Zhao, Chen Ma, Jie Yang, Xiufen Zou, Zishu Pan, 2021: Correction to: Dynamic Host Immune and Transcriptomic Responses to Respiratory Syncytial Virus Infection in a Vaccination-Challenge Mouse Model, Virologica Sinica, 36, 1684-1684. doi: 10.1007/s12250-021-00424-5
[2]
Yu Zhao, Chen Ma, Jie Yang, Xiufen Zou, Zishu Pan, 2021: Dynamic Host Immune and Transcriptomic Responses to Respiratory Syncytial Virus Infection in a Vaccination-Challenge Mouse Model, Virologica Sinica, 36, 1327-1340. doi: 10.1007/s12250-021-00418-3
[3]
Ningning Ge, Jin Sun, Zhihua Liu, Jiayi Shu, Huimin Yan, Zhihua Kou, Yu Wei, Xia Jin, 2022: An mRNA vaccine encoding Chikungunya virus E2-E1 protein elicits robust neutralizing antibody responses and CTL immune responses, Virologica Sinica, 37, 266-276. doi: 10.1016/j.virs.2022.01.032
[4]
Mengyuan Chen, Jiaqin Xu, Lingjun Ying, Miaoguo Cai, Tao-Hsin Tung, Kai Zhou, Yufen Zheng, Xiaojie Bi, Jing Wang, Xi Tu, Bo Shen, Dongqing Lv, 2022: Clinical practice of rapid antigen tests for SARS-CoV-2 Omicron variant: A single-center study in China, Virologica Sinica, 37, 842-849. doi: 10.1016/j.virs.2022.08.008
[5]
Shuhui Liu, Kaitao Zhao, Xi Su, Xiaoxiao Gao, Yongxuan Yao, Ranran Kong, Yun Wang, Chunchen Wu, Mengji Lu, Xinwen Chen, Rongjuan Pei, 2022: Enhanced host immune responses in presence of HCV facilitate HBV clearance in coinfection, Virologica Sinica, 37, 408-417. doi: 10.1016/j.virs.2022.04.001
[6]
邹罡, 青敏, 蔡全信, 袁志明, 2006: Expression of Domain III of the DENV-2 E Protein and Preparation of Anti-His-D2EIII Polyclonal Antibody, Virologica Sinica, 21, 619-621.
[7]
Hai-Bo Ding, Hong Sun, Yong-Hui Feng, Qing-Hai Hu, Qi Wang, Nan Li, Qing-Qing Ma, Wen Tian, Yan-Chun Peng, Jia-Qi Chen, Jin-Li Song, Hua-Lu Cui, Hai-Long Li, Wen-Qing Geng, Tao Dong, Xiao-Xu Han, Hong Shang, 2026: Characteristics of humoral and T-cell immune responses in people living with HIV after breakthrough SARS-CoV-2 Omicron variant infection during December 2022 to January 2023, Virologica Sinica, 41, 84-96. doi: 10.1016/j.virs.2026.01.003
[8]
Li Yuan, Wen-Jiang Chen, Jia-Ye Wang, Yan Li, Dan Tian, Ming-Xia Wang, Hao-Tong Yu, Ying-Chu Xu, Di Li, Min Zhuang, Hong Ling, 2018: Divergent Primary Immune Responses Induced by Human Immunodeficiency Virus-1 gp120 and Hepatitis B Surface Antigen Determine Antibody Recall Responses, Virologica Sinica, 33, 502-514. doi: 10.1007/s12250-018-0074-6
[9]
孙淑红, 崔治中, 邱玉玉, 2006: Immuno-Suppression of Reticuloendotheliosis Virus Infection on Antibody Responses to Different Vaccines in SPF chickens, Virologica Sinica, 21, 34-37.
[10]
Jiadai Li, Lingling Han, Yao Hao, Yuncong Yuan, Mingzhen Wang, Xiu Xin, Hailong Wang, Fang Yu, Congyi Zheng, Chao Shen, 2020: Comparative Transcriptome Analysis Reveals Different Host Cell Responses to Acute and Persistent Foot-and-Mouth Disease Virus Infection, Virologica Sinica, 35, 52-63. doi: 10.1007/s12250-019-00155-8
[11]
Yongmei Liu, Jianhua Lu, Haoting Zhan, Wenfang Yuan, Xiaomeng Li, Haiyan Kang, Haolong Li, Yongliang Chen, Linlin Cheng, Xingli Sun, Haojie Zheng, Wei Wang, Erhei Dai, Yongzhe Li, 2023: Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases, Virologica Sinica, 38, 723-734. doi: 10.1016/j.virs.2023.07.005
[12]
Yuming Li, Yanhong Tang, Xiaoqian Wang, Airu Zhu, Dongdong Liu, Yiyun He, Hu Guo, Jie Zheng, Xinzhuo Liu, Fengyu Chi, Yanqun Wang, Zhen Zhuang, Zhaoyong Zhang, Donglan Liu, Zhao Chen, Fang Li, Wei Ran, Kuai Yu, Dong Wang, Liyan Wen, Jianfen Zhuo, Yanjun Zhang, Yin Xi, Jingxian Zhao, Jincun Zhao, Jing Sun, 2024: Characterization of humoral immune responses against SARS-CoV-2 accessory proteins in infected patients and mouse model, Virologica Sinica, 39, 414-421. doi: 10.1016/j.virs.2024.04.005
[13]
Shouli Wu, Min Gao, Jian Zheng, Pingping Yan, Wei Wang, Xiaoli Lu, Yuefeng Qiu, Yansheng Yan, 2019: Prevalence of HIV Indeterminate Western Blot Tests and Follow-up of HIV Antibody Sero-Conversion in Southeastern China, Virologica Sinica, 34, 358-366. doi: 10.1007/s12250-019-00130-3
[14]
Lei Tan, Jun Yao, Yadi Yang, Wei Luo, Xiaomin Yuan, Lingchen Yang, Aibing Wang, 2021: Current Status and Challenge of Pseudorabies Virus Infection in China, Virologica Sinica, 36, 588-607. doi: 10.1007/s12250-020-00340-0
[15]
Yang Zheng, Qing Zhang, Ashaq Ali, Ke Li, Nan Shao, Xiaoli Zhou, Zhiqin Ye, Xiaomin Chen, Shanshan Cao, Jing Cui, Juan Zhou, Dianbing Wang, Baidong Hou, Min Li, Mengmeng Cui, Lihua Deng, Xinyi Sun, Qian Zhang, Qinfang Yang, Yong li, Hui Wang, Yake Lei, Bo Yu, Yegang Cheng, Xiaolin Tong, Dong Men, Xian-En Zhang, 2021: Sustainability of SARS-CoV-2 Induced Humoral Immune Responses in COVID-19 Patients from Hospitalization to Convalescence Over Six Months, Virologica Sinica, 36, 869-878. doi: 10.1007/s12250-021-00360-4
[16]
Jingyi Yang, Ejuan Zhang, Maohua Zhong, Qingyu Yang, Ke Hong, Ting Shu, Dihan Zhou, Jie Xiang, Jianbo Xia, Xi Zhou, Dingyu Zhang, Chaolin Huang, You Shang, Huimin Yan, 2020: Longitudinal Characteristics of T Cell Responses in Asymptomatic SARS-CoV-2 Infection, Virologica Sinica, 35, 838-841. doi: 10.1007/s12250-020-00277-4
[17]
Dong Fang, Yan Liu, Dou Dou, Bin Su, 2024: The unique immune evasion mechanisms of the mpox virus and their implication for developing new vaccines and immunotherapies, Virologica Sinica, 39, 709-718. doi: 10.1016/j.virs.2024.08.008
[18]
冷彦, 陈秀珠, 杜勇, 毛春生, 杜桂鑫, 王海涛, 2001: Preliminary Study of Hepatitis C Viral Quasispecies in NS2 Region in Patients wiUl Hepatitis C Virus Infection, Virologica Sinica, 16, 215-219.
[19]
Kangyin Li, Qi Liu, Yan Wu, Bihao Wu, Shaohong Chen, Xinghai Zhang, Xiaoying Jia, Rui Gong, Yucai Peng, Huajun Zhang, Sandra Chiu, 2024: A bivalent Delta/BA.5 mRNA vaccine elicits broad immune responses against various lineages of SARS-CoV-2 including JN.1, Virologica Sinica, 39, 833-835. doi: 10.1016/j.virs.2024.08.003
[20]
Jie Sheng, Lili Li, Xueying Lv, Meiling Gao, Ziyi Chen, Zhuo Zhou, Jingfeng Wang, Aiping Wu, Taijiao Jiang, 2023: Integrated interactome and transcriptome analysis reveals key host factors critical for SARS-CoV-2 infection, Virologica Sinica, 38, 508-519. doi: 10.1016/j.virs.2023.05.004